Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Final CTU new 2019 masthead1

Contraceptive Technology Update – May 1, 2014

May 1, 2014

View Archives Issues

  • Intrauterine contraception safe and effective in teens and adults

    Results from a recent retrospective analysis indicate that similar to adults, intrauterine device (IUD) use in adolescents and nulliparous women is effective and associated with low rates of serious complications.
  • Research stirs debate on mammography

    Results of a new study indicate that annual mammography in women ages 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available.
  • New treatment eyed for pain of vulvodynia

    Results of a new study indicate that vulvodynia incidence varies by age, ethnicity, and marital status, with a potential higher risk for women with pre-existing depression, sleep, or pain disorders.
  • Endometriosis is the focus of new scientific research

    Research has just provided a first step toward providing a more informed way of classifying endometriosis based on the underlying biological cause of the disease. Scientists might be able to develop a patient stratification system similar to that used for breast cancer patients, whose treatments are tailored to the molecular profile of their tumors.
  • Use guidance to cut stroke risks in women

    National guidelines have just been developed for preventing stroke in women. Stroke awareness is important, as one in five women will have a stroke in her lifetime. Stroke is the number three cause of death in women; about 55,000 more women than men die of stroke each year.
  • Generic EC — One step closer to OTC status

    The Food and Drug Administration is looking to generic versions of the levonorgestrel-based emergency contraception (EC) pill Plan B One-Step to submit applications for new labeling after the agency ruled the generic version can be sold on store shelves without restriction.
  • CTU Update